Knights of Columbus Asset Advisors LLC Raises Holdings in Integer Holdings Co. (NYSE:ITGR)

Knights of Columbus Asset Advisors LLC increased its holdings in Integer Holdings Co. (NYSE:ITGR) by 94.6% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 48,082 shares of the medical equipment provider’s stock after purchasing an additional 23,370 shares during the quarter. Knights of Columbus Asset Advisors LLC’s holdings in Integer were worth $4,764,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of ITGR. Fuller & Thaler Asset Management Inc. grew its holdings in Integer by 497.0% in the third quarter. Fuller & Thaler Asset Management Inc. now owns 536,343 shares of the medical equipment provider’s stock worth $42,065,000 after purchasing an additional 446,508 shares during the last quarter. Norges Bank acquired a new stake in shares of Integer in the fourth quarter valued at about $19,491,000. Victory Capital Management Inc. raised its position in shares of Integer by 27.8% in the fourth quarter. Victory Capital Management Inc. now owns 1,154,833 shares of the medical equipment provider’s stock valued at $79,060,000 after buying an additional 251,207 shares during the last quarter. Rockefeller Capital Management L.P. lifted its stake in shares of Integer by 1,226.1% in the first quarter. Rockefeller Capital Management L.P. now owns 223,876 shares of the medical equipment provider’s stock worth $17,350,000 after buying an additional 206,994 shares in the last quarter. Finally, Nomura Holdings Inc. acquired a new position in Integer during the first quarter worth $12,115,000. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Integer Stock Down 1.1 %

Shares of NYSE:ITGR opened at $116.58 on Friday. Integer Holdings Co. has a fifty-two week low of $69.40 and a fifty-two week high of $121.53. The firm’s 50 day moving average price is $111.82 and its 200 day moving average price is $98.49. The company has a quick ratio of 1.71, a current ratio of 2.80 and a debt-to-equity ratio of 0.64. The stock has a market cap of $3.91 billion, a price-to-earnings ratio of 43.34, a price-to-earnings-growth ratio of 1.63 and a beta of 1.10.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, February 15th. The medical equipment provider reported $1.39 EPS for the quarter, beating analysts’ consensus estimates of $1.34 by $0.05. The company had revenue of $413.15 million for the quarter, compared to the consensus estimate of $409.04 million. Integer had a net margin of 5.68% and a return on equity of 10.80%. The company’s quarterly revenue was up 10.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.11 EPS. As a group, equities research analysts predict that Integer Holdings Co. will post 5.31 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have issued reports on the company. CL King started coverage on Integer in a research report on Thursday, March 14th. They issued a “buy” rating and a $137.00 target price on the stock. KeyCorp lifted their price objective on shares of Integer from $123.00 to $139.00 and gave the company an “overweight” rating in a report on Tuesday, April 9th. Benchmark raised their price target on shares of Integer from $105.00 to $130.00 and gave the company a “buy” rating in a research report on Thursday, March 28th. Finally, Bank of America upgraded shares of Integer from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $105.00 to $135.00 in a research note on Monday, April 15th. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $120.50.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.